Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Plastic and Reconstructive Surgery
|
January 13, 2026
Perioperative Risk Factors and Long-Term Outcomes Using the Inferior Gluteal Artery Myocutaneous Flap to Reconstruct Complex Perineal Defects
Tavis Read, Peter Gearing, Michael Weymouth, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 23, 2015
Soft tissue reconstruction after compound tibial fracture: 235 cases over 12 years
Michael Wagels, Dan Rowe, Shireen Senewiratne, et al.
ANZ Journal of Surgery
|
August 25, 2018
Diagnosing phyllodes tumours of the breast: how successful are our current preoperative assessment modalities?
Nathan Yii, Tavis Read, Chuan Chien Tan, et al.
Journal of Surgical Oncology
|
January 16, 2019
Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study
Tavis Read, Warren Fayers, Janine Thomas, et al.
Journal of Surgical Oncology
|
February 24, 2017
Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma
Matthew Foote, Tavis Read, Janine Thomas, et al.
BMJ Open
|
October 9, 2017
Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study
Tavis Read, Scott Webber, Janine Thomas, et al.
Journal of Surgical Oncology
|
December 31, 2016
Primary cutaneous melanoma of the scalp: Patterns of recurrence
David S Sparks, Tavis Read, Michael Lonne, et al.
Journal of Surgical Oncology
|
February 9, 2019
A systematic review and meta-analysis of locoregional treatments for in-transit melanoma
Tavis Read, Michael Lonne, David S Sparks, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2020
Efficacy of immune checkpoint inhibitors for in-transit melanoma
Emilia Nan Tie, Julia Lai-Kwon, Michael Alexander Rtshiladze, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Plastic and Reconstructive Surgery
|
January 13, 2026
Perioperative Risk Factors and Long-Term Outcomes Using the Inferior Gluteal Artery Myocutaneous Flap to Reconstruct Complex Perineal Defects
Tavis Read, Peter Gearing, Michael Weymouth, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
June 23, 2015
Soft tissue reconstruction after compound tibial fracture: 235 cases over 12 years
Michael Wagels, Dan Rowe, Shireen Senewiratne, et al.
ANZ Journal of Surgery
|
August 25, 2018
Diagnosing phyllodes tumours of the breast: how successful are our current preoperative assessment modalities?
Nathan Yii, Tavis Read, Chuan Chien Tan, et al.
Journal of Surgical Oncology
|
January 16, 2019
Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study
Tavis Read, Warren Fayers, Janine Thomas, et al.
Journal of Surgical Oncology
|
February 24, 2017
Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma
Matthew Foote, Tavis Read, Janine Thomas, et al.
BMJ Open
|
October 9, 2017
Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study
Tavis Read, Scott Webber, Janine Thomas, et al.
Journal of Surgical Oncology
|
December 31, 2016
Primary cutaneous melanoma of the scalp: Patterns of recurrence
David S Sparks, Tavis Read, Michael Lonne, et al.
Journal of Surgical Oncology
|
February 9, 2019
A systematic review and meta-analysis of locoregional treatments for in-transit melanoma
Tavis Read, Michael Lonne, David S Sparks, et al.
Journal for Immunotherapy of Cancer
|
May 8, 2020
Efficacy of immune checkpoint inhibitors for in-transit melanoma
Emilia Nan Tie, Julia Lai-Kwon, Michael Alexander Rtshiladze, et al.
Page
of 1